Table of Contents
What changed
The release excerpts state continuing revenue rose 9.0% to NZ$122.3m and continuing NPAT rose 164.1% to NZ$143.2m against HY21. Operating profit before tax, however, was only NZ$62.5m in HY22, so roughly NZ$80.7m of the NPAT figure is attributable to fair-value and other non-operating items rather than trading profit.
Segment mix shifted materially. Mixed-use (NZ$58.1m revenue, 47.8% share) and Office (NZ$31.0m, 25.6%) remain the two primary reported segments, but Retail — previously 24.8% of revenue at roughly a 76.7% margin — is no longer separately disclosed. "Other" has expanded from 3.6% to 26.6% of revenue.
Balance sheet and cash moved in the wrong direction. Cash fell to NZ$11.3m from NZ$16.0m, gross borrowings rose NZ$19.0m to NZ$1,068.9m, taking net debt to about NZ$1,057.6m. Trade debtors jumped 68.9% to NZ$12.8m and receivable days stretched from 5.9 to 19.2. The interim dividend was declared at 2.75cps.
Note the calculation-pass comparators for revenue, NPAT and OCF use FY21 full-year figures, not HY21 half-year figures, so the headline "-47.8% revenue" and "-27.1% NPAT" deltas in that table are not like-for-like. The release's own +9.0% and +164.1% continuing-basis growth figures are the cleaner read.
What matters
- NPAT quality is revaluation-led. HY22 operating PBT of NZ$62.5m is less than half of reported NPAT of NZ$143.2m, and the effective tax rate of 11.0% is consistent with a large non-taxable revaluation component. The +164% NPAT headline should not be read as a trading outcome.
- Receivable days more than tripled. Trade debtors rose to NZ$12.8m against a much smaller revenue base, lifting days outstanding from about 6 to about 19. That is a direct drag on cash conversion and, combined with a NZ$19.0m rise in gross borrowings on NZ$4.7m of cash erosion, points to working-capital leakage in a tenancy book that was presumably still COVID-affected.
- Segment disclosure thinned. Dropping the separate Retail line, while "Other" swells to more than a quarter of revenue, reduces the reader's ability to triangulate like-for-like performance in the most discretionary income stream.
Expectations
No quantitative targets or forward-work metrics were disclosed in the supplied materials, so the release cannot be judged against guidance. Annualising HY22 revenue of NZ$121.4m gives about NZ$242.8m, roughly 4.4% above FY21's NZ$232.4m — consistent with a modest top-line rebuild but not a step-change. What this release supports is a recovery off a depressed HY21 base; what it does not support is an inference about second-half trading, because no shape commentary, occupancy bridge or rental collection update is quantified in the excerpts provided.
Quality of result
Durability is mixed. The operating PBT of NZ$62.5m is the defensible trading number, and operating cash flow of NZ$56.2m sits close to that figure — so the recurring earnings engine looks intact but is materially smaller than the NPAT headline implies. Capex of only NZ$0.1m (versus NZ$104.2m in the FY21 comparator) flattered pre-lease free cash flow to NZ$56.1m, meaning the FCF improvement is a capex pause, not an operating gain. Working capital is flashing amber: receivable days tripled, and a 6.8% reduction in interim DPS to 2.75cps — against the FY21 final of 2.95cps referenced in the release — implies the board saw cash coverage as tighter than NPAT suggests. On the calc pass, the interim dividend consumes roughly 77% of pre-lease FCF.
Unresolved
- What is the true HY22-versus-HY21 comparison for operating PBT, OCF, and dividend — the calculation-pass table and some excerpts blend FY21 full-year figures into the "prior" column.
- What sits in the expanded "Other" segment, and has Retail simply been reclassified rather than reported?
- What drove the jump in trade debtors — rental deferrals, specific tenants, or a timing item — and how much is provisioned?
- Why did gross borrowings step up NZ$19.0m despite minimal capex and positive OCF?
- Has the company restated HY21 on the new segment basis to allow a clean margin comparison?
This briefing cannot assess underlying tenant collection trends, the composition of the revaluation gain, or forward rental outlook, because none of those items are quantified in the supplied release excerpts.
Key metrics
| Metric | HY22 | HY21 | Change |
|---|---|---|---|
| Revenue | $121.4m | $232.4m | -47.8% ↓ |
| Net profit after tax | $143.2m | $196.5m | -27.1% ↓ |
| Net cash inflow from operating activities | $56.2m | $107.2m | -47.6% ↓ |
| Interim dividend per share | 2.8c | 2.9c | -6.8% ↓ |
| Profit before tax | $161.0m | $222.4m | -27.6% ↓ |
| Cash and cash equivalents | $11.3m | $16.0m | -29.6% ↓ |
| Total assets | $3476.3m | $3366.3m | +3.3% ↑ |
Reference: annolyse.ai/briefings/kpg-hy22
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Mixed-use | $58.1m | $107.7m | $44.0m | +1.5pp |
| Office | $31.0m | $58.7m | $23.9m | +0.3pp |
| Other | $32.3m | $8.4m | $24.5m | +23.0pp |
| Retail | — | $57.7m | — | n/a |
Reference: annolyse.ai/briefings/kpg-hy22
Analytical metrics
| Metric | HY22 | HY21 | Context |
|---|---|---|---|
| PBT growth | -27.6% | — | — |
| Effective tax rate | 11.0% | 11.6% | — |
| FCF pre-lease | $56.1m | $3.0m | +$53.1m |
| FCF / NPAT | 39.2% | 1.5% | complementary conversion metric |
| Capex % revenue | 0.1% | 44.8% | — |
| Capex | −$0.1m | −$104.2m | +$104.1m |
| Debtor days | 19.2 | 5.9 | +13.2 days |
| Trade debtors | $12.8m | $7.6m | +$5.2m |
| Net debt | $1057.6m | $1033.8m | +$23.7m |
| Gross borrowings | $1068.9m | $1049.9m | +$19.0m |
| Payout ratio vs NPAT | 30.2% | — | — |
| Payout ratio vs FCF pre-lease | 77.0% | — | covered |
| ROE (annualised) | 6.4% | 9.2% | Weakening |
| HY22 share of FY21 revenue | 52.2% | — | Other half was 47.8% |
| HY22 share of FY21 NPAT | 72.7% | — | Other half was 27.3% |
| Profit from continuing operations | $143.2m | — | — |
Reference: annolyse.ai/briefings/kpg-hy22
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.